mexiletine has been researched along with Myeloproliferative Disorders in 1 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erythromelalgia is a condition characterized by episodic pain, erythema and temperature of the extremities, which is relieved by cooling and aggravated by warming." | 2.61 | Review of primary and secondary erythromelalgia. ( King, T; Mann, N; Murphy, R, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mann, N | 1 |
| King, T | 1 |
| Murphy, R | 1 |
1 review available for mexiletine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Review of primary and secondary erythromelalgia.
Topics: Capsaicin; Erythromelalgia; Humans; Mass Screening; Mexiletine; Myeloproliferative Disorders; NAV1.7 | 2019 |